Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 956 of 5804
-
Can stem cells and Brain-Computer headsets slow memory loss?
Disease control Not yet recruitingThis study aims to evaluate the efficacy of community-based early detection and targeted interventions, including stem cell therapy and wearable non-invasive brain-computer interface (BCI) devices, for Mild Cognitive Impairment (MCI) in adults aged 55 years and older residing in …
Phase: EARLY_PHASE1 • Sponsor: Noah Tech, Corp. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Nerve-Freezing technique could revolutionize rib fracture recovery
Symptom relief Not yet recruitingThe goal of this double blinded randomized control trial is to learn if percutaneous cryoablation of traumatic rib fractures improves outcomes. The main questions it aims to answer are: Does percutaneous cryoablation improve short and long term pain scores? Does percutaneous cry…
Phase: NA • Sponsor: Loma Linda University • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Experimental immune cell cocktail targets tough lymphoma
Disease control Not yet recruitingThis research study is for people who have relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL) that has not responded to two or more lines of therapy. The purpose of this study is to identify the recommended dose of allogeneic NK cells in combination with IL-2, Tafasitamab…
Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
App-Based doula support tested for rural First-Time mothers
Symptom relief Not yet recruitingThis study will assess the impact of virtual doula care on birth and postnatal outcomes among rural mothers. The goal of virtual doula services is to improve access to care in underserved communities and decrease urban-rural differences in key maternal health outcomes including m…
Phase: NA • Sponsor: RAND • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New brain scanner could sharpen epilepsy surgery targeting
Diagnosis Not yet recruitingThe success of epilepsy surgery depends largely on the reliability of the preoperative localization of the epileptogenic zone. The conventional method for determining the area to be removed is based on a complex assessment involving an electroencephalogram (EEG) coupled with simu…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Eye exams could end guesswork in depression treatment
Knowledge-focused Not yet recruitingMajor depressive disorder (MDD) is a frequent and particularly disabling disorder. The efficacy of current antidepressants is limited, with 50-60% of patients not achieving a sufficient response to treatment. Indeed, to date, clinicians are unable to predict the therapeutic respo…
Phase: NA • Sponsor: Centre Psychothérapique de Nancy • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Engineered immune cells take on stomach cancer in early trial
Disease control Not yet recruitingThe goal of this clinical research study is to study the recommended dose of TROP2 CAR/IL-15 TGFBR2 KO NK cells that can be given intraperitoneally (infused directly into the stomach area) to participants with adenocarcinoma of the stomach that has spread to the peritoneum. The s…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a spinal implant ease chemo pain? new trial aims to find out
Symptom relief Not yet recruitingChemotherapy-induced peripheral neuropathy (CIPN) is a frequent and debilitating side effect of many cancer treatments. It affects 28 to 48% of patients receiving chemotherapy. Symptoms include tingling, numbness, burning sensations, and pain mainly in the hands and feet. While C…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New trial aims to match diabetes drugs to patients for better heart and kidney protection
Disease control Not yet recruitingBreakthrough T1D has awarded support for a joint University of Michigan-Oregon Health \& Science University Center of Excellence (CoE) to address cardio-renal complications in T1D. The overarching hypothesis of the CoE is that individuals with T1D have unique endophenotypes deter…
Phase: PHASE2 • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
AI brain coach aims to prevent dementia in singapore adults
Prevention Not yet recruitingThe goal of this clinical trial is to evaluate whether an AI-powered digital brain health coaching intervention can improve modifiable brain health risk factors in community-dwelling adults aged 40 and above in Singapore. The main question it aims to answer is: does the use of B…
Phase: NA • Sponsor: Alexandra Hospital • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Dispatcher training could boost cardiac arrest survival
Knowledge-focused Not yet recruitingOut-of-hospital cardiac arrest rate is common problem, because of high mortality rate. It is not clear incidence rate, epidemiology and outcomes in Lithuania
Sponsor: Lithuanian University of Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New hope for prostate cancer: drug combo aims to delay tumor growth
Disease control Not yet recruitingThis is a multi-center single arm phase II study of zanzalintinib after Pluvicto in chemotherapy-naïve mCRPC. Subjects will receive zanzalintinib 60mg orally (PO) once daily. Zanzalintinib may continue until evidence of radiographic progression, intolerable adverse events, or wit…
Phase: PHASE2 • Sponsor: Stuthi Perimbeti • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Which flu vaccine packs a bigger punch for people with HIV?
Prevention Not yet recruitingSeasonal influenza causes morbidity in people with impaired immunity, including adults with elder ages and other comorbidities \[1\]. Standard-dose inactivated influenza vaccines (IIV) may induce lower hemagglutination inhibition (HAI) titers and more rapid waning in these groups…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Prevention
Last updated Jun 27, 2026 13:07 UTC
-
Bladder cancer surgery: do stents help or hurt?
Disease control Not yet recruitingRadical Cystectomy (RC) remains the gold standard for localized muscle-invasive bladder cancer (MIBC); however, use of ureteral stents at time of surgery remains controversial without level 1 evidence to comment on risks or benefits of their use. RC complications commonly include…
Phase: PHASE3 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Pepper-Based patch may ease chronic pelvic pain by resetting nerve sensitivity
Symptom relief Not yet recruitingThe primary objective of this study will be to demonstrate a change in pain sensitization parameters before and after the application of the high-concentration capsaicin patch.
Phase: NA • Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Brain zap study probes inflammation link in Parkinson's
Knowledge-focused Not yet recruitingThe aim of the study is to characterize the neuroinflammatory effects of subthalamic deep brain stimulation in patients with Parkinson's disease, by analyzing changes in blood neuroinflammatory and neurodegenerative biomarkers before and after surgery (at 6 and 12 months, respect…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Could a natural brain chemical help tame cannabis cravings and lift mood?
Disease control Not yet recruitingThis is UG3 phase of a multi-site, milestone-driven UG3/UH3 research program evaluating pregnenolone for individuals with co-occurring cannabis use disorder (CUD) and major depressive disorder (MDD). Pregnenolone is a neurosteroid that modulates cannabinoid receptor signaling and…
Phase: PHASE1, PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can we predict brain fog in older women fighting ovarian cancer?
Knowledge-focused Not yet recruitingCognitive decline and delirium are common geriatric syndromes that adversely affect treatment adherence, functional independence, quality of life, and survival in older adults with cancer. Women aged 70 years and older with ovarian cancer are particularly vulnerable because of th…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Could trauma history sabotage epilepsy surgery? a new study investigates
Knowledge-focused Not yet recruitingWhy is this study being conducted? For people with drug-resistant focal epilepsy, surgery, to remove the part of the brain where seizures start, is currently the most effective treatment. In many people, especially those with temporal lobe epilepsy, surgery can stop seizures comp…
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Can a tiny zap during prostate surgery save erectile function?
Knowledge-focused ENROLLING_BY_INVITATIONThis prospective first-in-human feasibility study will evaluate the safety and feasibility of selective electrical stimulation of the neurovascular bundles (NVBs) during nerve-sparing robot-assisted radical prostatectomy (RARP). 20 adult patients with localized prostate cancer, n…
Phase: NA • Sponsor: University Medical Centre Ljubljana • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC